BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28536235)

  • 21. [Periodic synchronous discharge occurred in an elderly with acute valacyclovir-associated encephalopathy].
    Nakatani M; Tsukino M; Takahashi R; Ikeda A
    Rinsho Shinkeigaku; 2016 Jul; 56(7):504-7. PubMed ID: 27356736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valaciclovir-induced hepatitis.
    Renkes P; Trechot P; Blain H
    Acta Clin Belg; 1999; 54(1):17-8. PubMed ID: 10192972
    [No Abstract]   [Full Text] [Related]  

  • 23. Possible valacyclovir-related neurotoxicity and aseptic meningitis.
    Olin JL; Gugliotta JL
    Ann Pharmacother; 2003 Dec; 37(12):1814-7. PubMed ID: 14632597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clostridium difficile colitis associated with valaciclovir.
    De Andrés S; Ferreiro D; Ibánez M; Ballesteros A; García B; Agud JL
    Pharm World Sci; 2004 Feb; 26(1):8-9. PubMed ID: 15018252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Varicella-zoster meningitis with a late-onset of skin eruption.
    Sanguankeo A; Upala S; Sornprom S; Thamcharoen N
    BMJ Case Rep; 2015 Feb; 2015():. PubMed ID: 25691578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acyclovir-induced neuropsychosis successfully recovered after immediate hemodialysis in an end-stage renal disease patient.
    Yang HH; Hsiao YP; Shih HC; Yang JH
    Int J Dermatol; 2007 Aug; 46(8):883-4. PubMed ID: 17651180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Symmetrical drug-related intertriginous and flexural exanthema caused by valacyclovir.
    Daito J; Hanada K; Katoh N; Katoh S; Sakamoto K; Asai J; Takenaka H; Kishimoto S
    Dermatology; 2009; 218(1):60-2. PubMed ID: 18974630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neurotoxicity after the first dose of oral administration of valaciclovir in a female hemodialyzed patient].
    Saurina A; Ramírez de Arellano M; de las Cuevas X
    Nefrologia; 2002; 22(1):83-4. PubMed ID: 11987691
    [No Abstract]   [Full Text] [Related]  

  • 29. Neurotoxicity caused by valacyclovir in a patient on hemodialysis.
    Linssen-Schuurmans CD; van Kan EJ; Feith GW; Uges DR
    Ther Drug Monit; 1998 Aug; 20(4):385-6. PubMed ID: 9712461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case series using famciclovir in stem cell transplant recipients with valacyclovir hypersensitivity reactions.
    Shah SA; Gulbis A; Wilhelm K
    J Oncol Pharm Pract; 2015 Aug; 21(4):305-9. PubMed ID: 24714130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A patient with thyroid carcinoma who developed consciousness disturbance during acyclovir administration for herpes zoster].
    Matsumoto R; Yoshida T; Tabata K; Nakagawa S; Yanagisawa N
    Rinsho Shinkeigaku; 1996 Apr; 36(4):590-3. PubMed ID: 8810856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Valomaciclovir versus valacyclovir for the treatment of acute herpes zoster in immunocompetent adults: a randomized, double-blind, active-controlled trial.
    Tyring SK; Plunkett S; Scribner AR; Broker RE; Herrod JN; Handke LT; Wise JM; Martin PA;
    J Med Virol; 2012 Aug; 84(8):1224-32. PubMed ID: 22711350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Encephalopathy and acute renal failure during acyclovir treatment].
    Delluc A; Mocquard Y; Latour P; Goas JY
    Rev Neurol (Paris); 2004 Jul; 160(6-7):704-6. PubMed ID: 15247861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acyclovir Neurotoxicity in a Peritoneal Dialysis Patient: Report of a Case and Review of the Pharmacokinetics of Acyclovir.
    Sadjadi SA; Regmi S; Chau T
    Am J Case Rep; 2018 Dec; 19():1459-1462. PubMed ID: 30531673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurotoxicity of valacyclovir in peritoneal dialysis: a pharmacokinetic study.
    Izzedine H; Mercadal L; Aymard G; Launay-Vacher V; Martinez V; Issad B; Deray G
    Am J Nephrol; 2001; 21(2):162-4. PubMed ID: 11359026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of acyclovir and its metabolites in cerebrospinal fluid and systemic circulation after administration of high-dose valacyclovir in subjects with normal and impaired renal function.
    Smith JP; Weller S; Johnson B; Nicotera J; Luther JM; Haas DW
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1146-51. PubMed ID: 20038622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probable acyclovir-induced angioedema in a patient with HIV infection and suspected varicella-zoster virus encephalitis.
    Jen SP; Sharma R; Kochar S
    Am J Health Syst Pharm; 2011 Dec; 68(23):2257-60. PubMed ID: 22095814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurotoxicity associated with acyclovir and valacyclovir: A systematic review of cases.
    Brandariz-Nuñez D; Correas-Sanahuja M; Maya-Gallego S; Martín Herranz I
    J Clin Pharm Ther; 2021 Aug; 46(4):918-926. PubMed ID: 34146428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double-blind study comparing 2 dosages of valacyclovir hydrochloride for the treatment of uncomplicated herpes zoster in immunocompromised patients 18 years of age and older.
    Arora A; Mendoza N; Brantley J; Yates B; Dix L; Tyring S
    J Infect Dis; 2008 May; 197(9):1289-95. PubMed ID: 18422441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Choreiform movements in dialysis patient taking valacyclovir and famciclovir.
    Maru MC; Fialkow RZ; Haria DM
    South Med J; 2001 Jun; 94(6):655. PubMed ID: 11440337
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.